What is CorMedix's cumulative cost basis?

CorMedix (CRMD) reported cumulative cost basis of $8.5M in Q4 2025.

How has CorMedix's cumulative cost basis changed year-over-year?

CorMedix's cumulative cost basis decreased by 75.1% year-over-year, from $34.16M to $8.5M.

What is the long-term trend for CorMedix's cumulative cost basis?

Over 5 years (2020 to 2025), CorMedix's cumulative cost basis has grown at a 137.9% compound annual growth rate (CAGR), from $111.5K to $8.5M.

CorMedix CRMD Cumulative Cost Basis

Cumulative Cost Basis at other companies

Merit Medical SystemsMMSI

——

Emergent BiosolutionsEBS

——

AbbottABT

——

Mirum Pharmaceuticals, Inc.MIRM

——

HaemoneticsHAE

——

Becton, Dickinson and CompanyBDX

——

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's cumulative cost basis?: CorMedix (CRMD) reported cumulative cost basis of $8.5M in Q4 2025.
How has CorMedix's cumulative cost basis changed year-over-year?: CorMedix's cumulative cost basis decreased by 75.1% year-over-year, from $34.16M to $8.5M.
What is the long-term trend for CorMedix's cumulative cost basis?: Over 5 years (2020 to 2025), CorMedix's cumulative cost basis has grown at a 137.9% compound annual growth rate (CAGR), from $111.5K to $8.5M.